Borg Jacqueline, Andrée Bengt, Lundberg Johan, Halldin Christer, Farde Lars
Section of Psychiatry, Department of Clinical Neuroscience, Karolinska Institute, 17176 Stockholm, Sweden.
Psychopharmacology (Berl). 2006 Apr;185(3):389-94. doi: 10.1007/s00213-006-0329-z. Epub 2006 Mar 16.
Animal studies and studies of human aging have suggested that the serotonin 5-HT1A receptor may serve as a biomarker for cognitive functioning and a target for pharmacological treatment of cognitive deficits.
The purpose of this positron emission tomography (PET) study was to search for relationships between interindividual variability in serotonin 5-HT1A receptor binding potential (BP) and cognitive functioning.
Twenty-four male control subjects, age 20-55 years, were examined with [11C]WAY100635 PET and a battery of cognitive tests. 5-HT1A receptor binding potential were calculated for the raphe nuclei, the hippocampus and the neocortex. Correlation coefficients between BP and cognitive performance were obtained for each region.
There was a severalfold of variability in 5-HT1A BP between individuals. We found no significant correlation between regional [11C]WAY100635 binding and cognitive performance.
The results do not provide support for involvement of the 5-HT1A receptor in cognitive functioning in man and question the predictive validity of some currently used animal models in translational neuroscience.